GlassScriptPhysician profile
William S Ragon
NPI 1063535979
$2,781.56
in general payments reported to CMS, 2019-2025
25 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $161 · 2021: $250 · 2022: $884 · 2023: $352 · 2024: $510 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,201.68 | 2019-2023 | Legion Revision, Real Intelligence |
| Depuy Synthes Sales INC. | $527.60 | 2019-2025 | Tfn-Advance, Motoband, Na |
| Amgen INC. | $140.55 | 2021-2024 | Evenity, Prolia |
| Djo, LLC | $128.83 | 2023-2025 | Cmf |
| Ferring Pharmaceuticals INC. | $115.30 | 2019-2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $113.28 | 2022-2024 | Exparel, Zilretta, Iovera |
| Vertos Medical, INC. | $76.97 | 2022-2024 | Mild Device Kit |
| Radius Health, INC. | $69.38 | 2019-2023 | Tymlos |
| Convatec INC. | $54.31 | 2022-2024 | |
| Heron Therapeutics, INC. | $43.95 | 2022-2024 | Zynrelef |
| Stryker Corporation | $41.00 | 2024-2025 | System 9 Cd Nxt |
| Orthofix Medical, INC. | $36.13 | 2022-2023 | Physio-Stim |
| Pacira Therapeutics, INC. | $25.68 | 2019 | |
| Boston Scientific Corporation | $23.33 | 2023 | Wavewriter Alpha Prime 16 |
| Wright Medical Technology, INC. | $22.20 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.19 | 2021 | |
| Fidia Pharma USA INC. | $20.14 | 2021 | |
| Merck Sharp & Dohme LLC | $18.40 | 2023 | Bridion |
| Acelrx Pharmaceuticals, INC. | $18.09 | 2021 | |
| Baudax Bio INC. | $17.06 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.48 | 2020 | |
| Medtronic, INC. | $14.42 | 2024 | V-Loc 180 |
| Gentleman Orthopedic Solutions | $13.03 | 2023 | |
| Zyla Life Sciences, INC. | $11.33 | 2019 | |
| Heraeus Medical, LLC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ragon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.